The Compliance Documentation Gap
The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) fundamentally changed the regulatory landscape for cosmetics manufacturers, requiring facility registration and product listing with the FDA. Yet a peculiar friction has emerged between what e-commerce platforms demand and what the agency actually provides.
Major online marketplaces—including Amazon, Walmart Marketplace, and others—have implemented seller verification programs requiring cosmetics brands to upload "FDA registration certificates" or "proof of FDA compliance" before listing products in beauty and personal care categories. The problem is straightforward: no such certificate exists.
What FDA Actually Provides Under MoCRA
MoCRA established two primary obligations for responsible persons and facilities:
- Facility registration — Cosmetic product facilities must register with FDA, renewing biennially.
- Product listing — Responsible persons must submit product listings identifying ingredients and other statutorily required information.
When a facility completes registration through FDA's electronic portal (Cosmetics Direct), the system generates a confirmation showing the submission was received and assigned a facility registration number. This is fundamentally an acknowledgment of a filing, not a certification of compliance, safety, or quality.
FDA has been explicit in public statements and guidance materials that it does not:
- Issue certificates attesting to a facility's or product's compliance status
- Approve cosmetic products or ingredients before marketing (with limited exceptions such as color additives)
- Provide letters confirming that a company meets all applicable regulatory requirements
- Endorse or authenticate compliance for use in commercial transactions
This is consistent with the broader architecture of cosmetics regulation, which—unlike drugs or medical devices—does not require premarket approval. Registration confirms that FDA has record of a facility's existence and a product's listing; it says nothing about whether the product is safe, properly labeled, or manufactured in accordance with Good Manufacturing Practice expectations.
The Marketplace Mismatch
E-commerce platforms, seeking to reduce liability exposure and satisfy their own risk-management protocols, have built compliance verification systems that assume a certificate-based regulatory model similar to what exists in other industries (e.g., organic certification, UL listing, or FDA drug establishment registration in some contexts). Cosmetics regulation does not fit this model.
Sellers attempting to satisfy platform requirements face a genuine dilemma:
- They cannot produce a document that does not exist.
- Platform compliance teams may reject registration confirmation printouts as insufficient.
- Accounts can be suspended or listings removed for failure to provide "proof," regardless of actual regulatory standing.
- Some sellers have resorted to purchasing third-party "FDA certification" services—many of which are themselves misleading or fraudulent, since no legitimate entity can issue an FDA compliance certificate on the agency's behalf.
This dynamic creates commercial risk that is disproportionate to actual regulatory risk. A fully compliant brand may find itself locked out of marketplace sales channels simply because it cannot manufacture paperwork that FDA itself does not generate.
Practical Steps for Brands and Responsible Persons
Companies navigating this gap should consider a documented, defensible approach:
1. Assemble a compliance file, not a certificate.
Maintain organized records including:
- Facility registration confirmation and registration number
- Product listing confirmations for each SKU
- Safety substantiation records required under MoCRA
- Labeling review documentation
- Adverse event reporting procedures
2. Draft a compliance narrative letter.
A letter from the responsible person or counsel explaining the regulatory framework, referencing the facility registration number, and clarifying that FDA does not issue compliance certificates can often satisfy platform reviewers who are unfamiliar with cosmetics-specific rules.
3. Engage directly with platform seller support.
When automated systems reject submissions, escalate to human review with clear regulatory citations. Platforms are increasingly encountering this issue across many sellers and, in some cases, have adjusted internal guidance once presented with accurate information.
4. Avoid third-party "certification" vendors.
Any company offering to sell an "FDA Certificate of Registration" or similar document for cosmetics should be treated with skepticism. Reliance on such documents in marketplace disputes could itself create legal and reputational exposure.
5. Monitor FDA public communications.
FDA has periodically issued clarifying statements addressing confusion in the marketplace about registration versus certification. Staying current on these statements provides useful language for platform correspondence.
Strategic and Legal Considerations
From a risk-management perspective, this issue sits at the intersection of regulatory compliance and commercial contract law. Marketplace seller agreements typically grant platforms broad discretion to suspend accounts for perceived non-compliance, even where the underlying demand is not legally coherent. Brands should:
- Review marketplace seller agreements for dispute resolution and appeal mechanisms
- Preserve all correspondence with platform compliance teams
- Consider whether repeated erroneous suspensions warrant formal legal correspondence or platform-level escalation
For larger brands operating across multiple marketplaces, a standardized compliance packet—vetted by counsel—can reduce friction and provide consistent, defensible documentation across all sales channels.
Looking Ahead
As MoCRA implementation matures and FDA continues to refine its registration systems, some convergence between marketplace expectations and regulatory reality is likely. Until then, cosmetics companies must proactively manage this documentation gap rather than assume platforms understand the nuances of cosmetics-specific regulation. Sophisticated compliance planning—grounded in accurate regulatory understanding rather than reactive paperwork production—remains the most effective strategy for maintaining uninterrupted marketplace access while satisfying genuine MoCRA obligations.